OptiNose (OPTN) & Editas Medicine (EDIT) Head-To-Head Survey – The Ledger Gazette
|
OptiNose (OPTN) & Editas Medicine (EDIT) Head-To-Head Survey
The Ledger Gazette It is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 … |
